BioSpace News Archive

Cerner Corporation, a global health care technology company, recognizes Cornwall Community Hospital for receiving Canada’s highest level of accreditation through Accreditation Canada’s Qmentum International Accreditation Program.

Vertex Pharmaceuticals Incorporated will report its full-year and fourth-quarter 2019 financial results on Thursday, January 30, 2020 after the financial markets close.

The Marchand Institute for Minimally Invasive Surgery released a warning regarding new lines of small adult toys that are marketed as being as wearable as fashion jewelry and doubling as a functioning vibrating adult toy.

Adaptive Biotechnologies Corporation announced the commencement of a proposed underwritten public offering of 8,000,000 shares of its common stock by certain selling shareholders.

Eisai announced the presentation of three abstracts at the 2020 Gastrointestinal Cancers Symposium in San Francisco from January 23-25.

Cognate BioServices, a leading contract development and manufacturing organization specialized in cell and cell-mediated gene therapy products announced that it has completed the acquisition of Cobra Biologics, a leading CDMO specialized in providing development and manufacturing services for plasmid DNA and viral vector.

The Center for Neurological and Neurodevelopmental Health announced that it began mailing letters to patients potentially impacted by a recent incident.

SPN-812 (viloxazine hydrochloride), a once-daily novel serotonin norepinephrine modulating agent (SNMA), demonstrates a reduction in ADHD-RS-5 total score as early as Week 1 and continuing until the end of the pivotal clinical studies

PhotoDynamic Therapy is a highly effective procedure used in the treatment of a variety of dermatological disorders.

Centene Corporation announced the final results of the offers to exchange notes issued by WellCare Health Plans, Inc. for up to $1,950,000,000 aggregate principal amount of new notes to be issued by Centene and cash and the related consent solicitations made by Centene on behalf of WellCare to adopt certain proposed amendments to the indentures governing the WellCare Notes.